Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2747-2026

MEDLINE ANTERIOR HIP, Medline Kit SKU DYNJ909640G Recall

MEDLINE ANTERIOR HIP, Medline Kit SKU DYNJ909640G

FDA recall Class I

Ongoing

FDA lists this Class I recall for MEDLINE ANTERIOR HIP, Medline Kit SKU DYNJ909640G. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2747-2026
Recall classification
Class I
Enforcement status
Ongoing
Initiation date
Jun 5, 2026
FDA report date
Jul 29, 2026
Quantity in commerce
60 kits
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

MEDLINE ANTERIOR HIP, Medline Kit SKU DYNJ909640G

Affected model & UDI checker

Search the exact identifiers published for Z-2747-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedMEDLINE ANTERIOR HIP, Medline Kit SKU DYNJ909640GCheck source notice10198459280559
Not specifiedMEDLINE ANTERIOR HIP, Medline Kit SKU DYNJ909640GCheck source notice40198459280550
FDA code information

UDI/DI 10198459280559 (each) 40198459280550 (case), Lot Number 25DBF430

View the original FDA recall notice

Why was this product recalled?

Medline Industries, LP is issuing a recall for specific Medline kits containing B. Braun convenience kits that include Bupivacaine Hydrochloride in Dextrose Injection, USP. B. Braun Medical Inc. was notified by their supplier, Spectra Medical Devices, LLC of a product recall from Huons Co, Ltd., the manufacturer of Bupivacaine Hydrochloride in Dextrose Injection, USP. Huons Co, Ltd. has issued a voluntary recall of this product due to quality issues.

What actions did Medline Industries, LP take?

Medline Industries, LP issued an URGENT MEDICAL DEVICE RECALL notice to its consignees on 6/5/2026 via USPS and email. The notice explained the issue, potential risk to health, and requested the following: identify and quarantine product, and complete response and return the response form using the Website link: https://recalls.medline.com. Those who further distributed the affected product have been directed to notify their customers. Upon receipt of the submitted response form, the consignee will receive over-labels to place on affected inventory, with instructions for your staff to remove and discard the affected component prior to using the kit. These labels will be provided via FedEx overnight, if applicable. For questions, contact the Recall Department at 866-359-1704 or recalls@medline.com.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology